» Articles » PMID: 20685224

Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Development, Surface Modification and Applications in Chemotherapy

Overview
Specialty Pharmacology
Date 2010 Aug 6
PMID 20685224
Citations 333
Authors
Affiliations
Soon will be listed here.
Abstract

At present, nanoparticles are used for various biomedical applications where they facilitate laboratory diagnostics and therapeutics. More specifically for drug delivery purposes, the use of nanoparticles is attracting increasing attention due to their unique capabilities and their negligible side effects not only in cancer therapy but also in the treatment of other ailments. Among all types of nanoparticles, biocompatible superparamagnetic iron oxide nanoparticles (SPIONs) with proper surface architecture and conjugated targeting ligands/proteins have attracted a great deal of attention for drug delivery applications. This review covers recent advances in the development of SPIONs together with their possibilities and limitations from fabrication to application in drug delivery. In addition, the state-of-the-art synthetic routes and surface modification of desired SPIONs for drug delivery purposes are described.

Citing Articles

Anxiety of microbially synthesized FeO-SPIONs on embryonic/larval ontogeny in red tilapia (Oreochromis sp.).

Abouelkheir S, Mourad M Appl Microbiol Biotechnol. 2025; 109(1):3.

PMID: 39777547 PMC: 11706909. DOI: 10.1007/s00253-024-13386-x.


Carbapenem-Resistant Adherence to Magnetic Nanoparticles.

Caliskan-Aydogan O, Zaborney Kline C, Alocilja E Nanomaterials (Basel). 2024; 14(24).

PMID: 39728546 PMC: 11678732. DOI: 10.3390/nano14242010.


Utilization of nanomaterials in MRI contrast agents and their role in therapy guided by imaging.

Wang W, Shang S, Wang Y, Xu B Front Bioeng Biotechnol. 2024; 12:1484577.

PMID: 39628648 PMC: 11611570. DOI: 10.3389/fbioe.2024.1484577.


The Optical Forces and Torques Exerted by Airy Light-Sheet on Magnetic Particles Utilized for Targeted Drug Delivery.

Song N, Chen S, Wang H, He X, Wei B, Li R Micromachines (Basel). 2024; 15(11).

PMID: 39597181 PMC: 11596985. DOI: 10.3390/mi15111369.


Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer.

Sai B, Dinakar Y, Kumar H, Jain R, Kesharwani S, Kesharwani S Ther Deliv. 2024; 15(11):871-891.

PMID: 39320858 PMC: 11498026. DOI: 10.1080/20415990.2024.2400044.